4//SEC Filing
Arbuckle Stuart A 4
Accession 0001104659-25-063071
CIK 0001649904other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:37 PM ET
Size
8.3 KB
Accession
0001104659-25-063071
Insider Transaction Report
Form 4
Arbuckle Stuart A
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-24+7,037→ 7,037 totalExercise: $63.66Exp: 2035-06-23→ Common Stock (7,037 underlying) - Award
Restricted Stock Units
2025-06-24+4,712→ 4,712 total→ Common Stock (4,712 underlying)
Footnotes (3)
- [F1]The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F3]The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001557290
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:37 PM ET
- Size
- 8.3 KB